Community/Retail

The FDA has expanded the use of the anticoagulant apixaban (Eliquis) to treat deep vein thrombosis and pulmonary embolism.

Promising treatment protects nonhuman primates from Marburg virus up to 3 days after infection.

The FDA has approved the first needle-free device for injecting the Afluria influenza vaccine in adult patients aged 18 to 64 years.

The FDA has approved the first zinc transporter 8 autoantibody test that may help patients with type 1 diabetes mellitus receive more timely diagnosis and treatment for the disease.

The viral Ice Bucket Challenge and the first effort to estimate the prevalence of amyotrophic lateral sclerosis have raised awareness of the neurodegenerative disease.

The FDA has granted approval to Genzyme's eliglustat (Cerdelga), the only first-line oral therapy for patients with Type 1 Gaucher disease.

A new drug was recently given tentative approval by the FDA to help patients with both type 1 and type 2 diabetes.

Discover more about the value pharmacists provide to patients every day.

Doctors Without Borders says virus cannot be contained without massive mobilization of resources to West Africa.

Amgen's investigational treatment for secondary hyperparathyroidism in patients with chronic kidney disease who are receiving hemodialysis achieved its primary and secondary endpoints in a second Phase 3 study.

Key points from the Infectious Diseases Society of America's updated guidelines for vaccination of immunocompromised individuals.

We should not be ashamed to talk openly about something that is nothing more than a neurotransmitter imbalance.

Patients continue to benefit from high-dose atorvastatin therapy for at least 5 years after acute coronary syndrome, according to a new study.

Many patients with Parkinson's disease do not receive treatment for their depressive symptoms.

Ebola-related death toll climbs above 1200 as health care workers face increased threats from desperate region.

Mylan, Inc, has launched a therapeutically equivalent version of Precedex, while Hospira, Inc, has filed a lawsuit to challenge the generic approval.

Exposure to daylight improved the health and mood of both office employees and nurses working in an acute care facility.

Grocery store chain joins growing list of major companies offering enhanced specialty pharmacy.

Curcumin, a component of the traditional Indian spice, turmeric, is highly effective in combating the symptoms of major depressive disorder.

John Zajecka, MD, speaks about the different types of bipolar disorder in this video produced by the Depression and Bipolar Support Alliance.

In this video from the Medical University of South Carolina, Frederick K. Goodwin, MD, provides in-depth information on the diagnosis and treatment of bipolar disorder.

This video produced by the Depression and Bipolar Support Alliance provides information on the symptoms of bipolar disorder, offering insights from the perspectives of clinicians, patients, and their family members.